Launching in 2026, IJTLD Chronic Respiratory Disease (IJTLD CRD) is a new open access journal (fully compliant with Plan S).
The Journal will feature the latest research on chronic lung conditions in LMICs to improve access to knowledge and influence care, policy and practise for better health.
Each issue of IJTLD CRD will include a mix of articles, including: PTLD – Asthma – COPD – Impact of air pollution – Lung damage in smokers – Interstitial lung disease – Bronchiectasis – Long COVID – Sleep apnea – Occupational lung disease – Interventional pulmonology.
This critically neglected area accounts for an estimated 4 million annual deaths and affects 28–90 million people with PTLD.
We encourage authors working on chronic respiratory disease to submit their latest research on all aspects of the management and care of patients. We will consider Editorials, Meeting Reports, Original Research (including methodology papers and qualitative research), Reviews, Viewpoints, Study Protocols, Case Series, Case Reports and Letters.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions. Our aim is to highlight the importance of these conditions to influence policymakers and improve clinical care in LMICs.
For all queries please e-mail the Editorial team at journal@theunion.org
While preparing their article, authors should refer to the Instructions for Authors to check that they have complied with our requirements – see links below.
Once complete, authors should submit their manuscripts at http://mc.manuscriptcentral.com/ijtld
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD CRD has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available and acknowledge the sponsors support and readers will receive emails to highlight sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Responding to COVID-19: adjusting TB services in a low-burden setting
A letter to the editors in which the Victorian Tuberculosis Program describes how the social and programmatic changes to TB services brought on by COVID-19 have been experienced in practice.
COVID-19 in Africa: community and digital technologies for tuberculosis management
This letter explores the concerns about the negative impact that COVID-19 will have on the fight against tuberculosis in Africa
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic
This letter looks at the implications and potential consequences of delayed or missed diagnoses for TB, which may increase TB-related hospitalisations and death.
COVID-19 and tuberculosis—threats and opportunities
In an editorial to the IJTLD, the authors state how we must overcome the challenges that COVID-19 presents and use the opportunities it affords us to achieve a paradigm shift in TB treatment and care
Common concerns in managing bronchial asthma during the COVID-19 pandemic
A letter to the editors of the IJTLD addresses the major concern of use of corticosteroids and nebulised bronchodilators in bronchial asthma during the COVID-19 pandemic
Severe COVID-19 cases with a history of active or latent tuberculosis
In a letter to the editors, authors report on symptom development, disease progression and treatment for three cases, each representing a different TB scenario.